1-3 of 3
Caroline E. Weibull
Close
Sort by
Journal Articles

Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy–treated mantle cell lymphoma

Anna Nikkarinen, Lavanya Lokhande, Rose-Marie Amini, Mats Jerkeman, Anna Porwit, Daniel Molin, Gunilla Enblad, Arne Kolstad, Riikka Räty, Martin Hutchings, Caroline E. Weibull, Peter Hollander, Sara Ek, Ingrid Glimelius
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5304–5313.
https://doi.org/10.1182/bloodadvances.2023010052
Published: 2023
Includes: Supplemental data
Journal Articles

Late effects in patients with mantle cell lymphoma treated with or without autologous stem cell transplantation

Clinical Trials & Observations
Sara Ekberg, Karin E. Smedby, Alexandra Albertsson-Lindblad, Mats Jerkeman, Caroline E. Weibull, Ingrid Glimelius
Journal: Blood Advances
Blood Adv (2023) 7 (5): 866–874.
https://doi.org/10.1182/bloodadvances.2022007241
Published: 2023
Includes: Supplemental data
Journal Articles

Unmarried or less-educated patients with mantle cell lymphoma are less likely to undergo a transplant, leading to lower survival

Clinical Trials & Observations
Ingrid Glimelius, Karin E. Smedby, Alexandra Albertsson-Lindblad, Michael J. Crowther, Sandra Eloranta, Mats Jerkeman, Caroline E. Weibull
Journal: Blood Advances
Blood Adv (2021) 5 (6): 1638–1647.
https://doi.org/10.1182/bloodadvances.2020003645
Published: 2021
Includes: Supplemental data